三阴性乳腺癌的免疫疗法:对微环境,治疗和耐药性的分子洞察力
Xupeng Bai1,2, Jie Ni1,2, Julia Beretov1,2,3
1St George and Sutherland Clinical School, Faculty of Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Journal of the National Cancer Center
|July 22, 2024
概括
三阴性乳腺癌 (TNBC) 显示免疫疗法具有前景,但许多患者反应不佳. 本综述探讨了TNBC的免疫微环境和对免疫检查点抑制剂 (ICI) 的耐药性,以改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 三阴性乳腺癌 (TNBC) 缺乏向疗法,限制了治疗选择.
- 瘤内在的免疫逃生机制是理解TNBC进展的关键.
- 与其他乳腺癌亚型相比,TNBC对免疫治疗的反应率更高.
研究的目的:
- 审查TNBC免疫疗法的最新进展.
- 讨论在TNBC中克服ICI抵抗的挑战和潜在策略.
- 探索TNBC免疫微环境及其在治疗反应中的作用.
主要方法:
- 关于TNBC免疫治疗的最新研究的文献综述.
- 在TNBC中分析瘤突变负担和淋巴细胞透.
- 检查免疫检查点抑制剂 (ICI) 的有效性和耐药性机制.
主要成果:
- 由于较高的瘤突变负担和淋巴细胞透,TNBC对免疫疗法的反应更好.
- 免疫检查点抑制剂 (ICI) 在TNBC中是有效的,但面临的挑战是无反应和获得的耐药性.
- 了解TNBC免疫微环境对于提高免疫疗法疗效至关重要.
结论:
- 免疫疗法,特别是ICI,为TNBC治疗提供了一个有前途的途径.
- 解决ICI耐药性和不响应是提高临床效益的关键.
- 对TNBC免疫微环境的进一步研究可以指导新的治疗策略.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


